Medigen Vaccine Biologics
Scope
Date
~
-
Bio & Pharma
Samsung Biologics bags $514 mn CMO contract from US pharma
Samsung Biologics Co., the world’s largest contract manufacturing organization (CMO), said on Monday it has secured a $5.14 million order from...
Apr 28, 2025 (Gmt+09:00)
-
Bio & Pharma
Chong Kun Dang to build new plant for foray into biologics market
Chong Kun Dang Pharmaceutical Corp. is discussing building a research center and a plant in Siheung, about 30 kilometers southwest of Seoul, with th...
Feb 27, 2025 (Gmt+09:00)
-
Korean stock market
Samsung Biologics shares fly high to be Korea’s third most valuable firm
Samsung Biologics Co., the world’s largest contract drugmaker, has become South Korea’s third most valuable stock on the country’s...
Feb 07, 2025 (Gmt+09:00)
-
Earnings
Samsung Biologics posts record 2024 sales, operating profit as it goes global
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, on Wednesday posted its largest-ever annual sales and operating p...
Jan 22, 2025 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics eyes first ADC CDMO order in 2025
SAN FRANCISCO -- Lotte Biologics Co., the drug consignment development and production unit of South Korean conglomerate Lotte Group, will seek to wi...
Jan 17, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs $1.4 bn CMO deal with European pharma
South Korea's Samsung Biologics Co., the world’s largest contract drugmaker, said on Tuesday it signed a $1.4 billion contract manufacturing o...
Jan 14, 2025 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs initial deal with LigaChem Bio on ADC production
Samsung Biologics Co., the world’s largest contract drugmaker, said on Thursday it has signed an initial agreement with LigaChem Biosciences I...
Jan 09, 2025 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience, Sanofi to develop next-gen pneumococcal vaccines
South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...
Dec 23, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics wins $668 million CDMO deal with European pharma
Samsung Biologics Co., the world’s largest contract drugmaker, said on Wednesday it has signed two drug manufacturing contracts worth a combin...
Nov 20, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience's SKYCellflu approved in Indonesia
SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...
Oct 24, 2024 (Gmt+09:00)
-
Korean startups
Enormous market ahead for Hopae, S.Korean DID pioneer
To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...
Aug 22, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience sells stake in US vaccine developer Novavax
SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...
Aug 16, 2024 (Gmt+09:00)
-
Bio & Pharma
IMBiologics transfers autoimmune disease drug tech to Huadong Pharma
South Korea's antibody-based biotech company IMBiologics announced on Friday that it signed a contract to transfer the technology of its autoimmune ...
Aug 16, 2024 (Gmt+09:00)
-
Korean stock market
Biotech stocks, foreigners’ top pick in Korea amid panic selling
Foreigners and institutional investors in the South Korean stock market picked biotechs as their favorite shares in hopes of a biopharma stock jump ...
Aug 11, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung’s biotech duo on a roll with $1.1 bn CMO order
Samsung Group is on track to rise to the top of biosimilar companies in the world and become South Korea’s largest drug maker for contract man...
Jul 03, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics targets $1.1 billion in sales with new bio plants
South Korean biopharmaceutical company Lotte Biologics Co. said on Wednesday it is aiming for 1.5 trillion won ($1.1 billion) in annual sales by 203...
Jul 03, 2024 (Gmt+09:00)
-
Mergers & Acquisitions
SK Bioscience to buy German vaccine maker IDT Biologika for $244 mn
South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...
Jun 27, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes windfall gain amid US-China row
SAN DIEGO – Samsung Biologics Co. is enjoying a stream of contract development and manufacturing order inquiries from big pharmaceutical compa...
Jun 07, 2024 (Gmt+09:00)
-
Bio & Pharma
EuBiologics gets WHO certification for cholera vaccine facility
South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...
May 17, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience exports Sky Cellflu to Thailand
South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...
Mar 21, 2024 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics signs ADC CDO deal with LegoChem Bio
Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...
Feb 07, 2024 (Gmt+09:00)
-
Bio & Pharma
Lotte Biologics, NJ Bio to jointly develop ADC
South Korea's Lotte Biologics Co. announced on Monday that it has signed a strategic business agreement with NJ Bio, a US-based preclinical and clin...
Jan 22, 2024 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience start to deliver Novavax COVID-19 vaccine
South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...
Dec 12, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience applies Phase 3 trials in US for pneumococcal vaccine
South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...
Dec 11, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics reaches record-breaking annual orders
Samsung Biologics Co., the world’s top contract manufacturing organization (CMO) by capacity, surpassed the annual contract manufacturing orde...
Nov 28, 2023 (Gmt+09:00)
-
Bio & Pharma
Korea to invest $200 mn in new drugs, vaccines by 2028
South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
GC Biopharma wins $10 mn order for flu vaccine in Thailand
South Korea's GC Biopharma Corp. announced on Thursday that its flu vaccine GC Flu secured a $10 million order in the upcoming bid by Thailand's Gov...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
KAIST, IVI to collaborate on global vaccine research
The Korea Advanced Institute of Science & Technology (KAIST) announced on Thursday that it signed a memorandum of understanding (MOU) with the I...
Nov 23, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Bioscience to develop 2nd-generation Ebola vaccine
South Korea's SK Bioscience Co. announced on Wednesday that it signed a business agreement with the international non-profit research organization H...
Nov 22, 2023 (Gmt+09:00)
-
Bio & Pharma
Lotte builds US antibody-drug conjugate plant with $82 mn
South Korea’s Lotte Biologics Co. is establishing an antibody-drug conjugate (ADC) factory in Syracuse, New York, with an investment of 110 bi...
Oct 31, 2023 (Gmt+09:00)
Latest News
- 1 BMW surpasses Mercedes in Korean sales amid imported vehicle market shake-up
- 2 Seoul appeal: Korean art captivates Indonesia’s affluent connoisseurs
- 3 CJ CheilJedang scraps $3.5 bn green bio sale, shifts gears to expansion
- 4 Trump Jr. meets Korean business chiefs in back-to-back sessions
- 5 Samsung in talks to supply customized HBM4 to Nvidia, Broadcom, Google